NCT01515995 Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation Status COMPLETED Phase PHASE4
NCT01514760 A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans Status COMPLETED Phase NA
NCT01511367 Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients Status COMPLETED Phase PHASE3
NCT01511302 Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma Status COMPLETED Phase PHASE1
NCT01509183 Effectiveness of the Propeller Health (Formerly Asthmapolis) Monitoring System Status COMPLETED Phase NA
NCT01508078 Characterization of Adult Subjects for Asthmatic Research Studies Status SUSPENDED Phase N/A
NCT01504646 Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma Status COMPLETED Phase NA
NCT01502371 A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223) Status COMPLETED Phase PHASE2
NCT01501942 Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma Status COMPLETED Phase PHASE2
NCT01500525 Bronchodilator Response in 4-12 Years Chinese Controller Naive Asthmatic Children Status COMPLETED Phase N/A
NCT01499446 A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma. Status COMPLETED Phase PHASE2
NCT01498679 Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry. Status COMPLETED Phase PHASE3
NCT01498653 Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry Status COMPLETED Phase PHASE3
NCT01497691 Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations Status WITHDRAWN Phase NA
NCT01494610 Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Status COMPLETED Phase PHASE1/PHASE2
NCT01493882 Study of JNJ-39758979 in Symptomatic Adult Patients With Uncontrolled Asthma Status WITHDRAWN Phase PHASE2